Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Local Anesthesia for Prostate Biopsy
- Status
- COMPLETED
- Phase
- PHASE4
Acupuncture Treatment for Hot Flashes Study
- Status
- COMPLETED
- Phase
- NA
Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Active Surveillance for Prostate Cancer With Indolent Features
- Status
- UNKNOWN
- Phase
- N/A
Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
- Status
- COMPLETED
- Phase
- NA
Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia
- Status
- COMPLETED
- Phase
- NA
Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Intensity Modulated Versus Interstitial - Radiation Therapy
- Status
- UNKNOWN
- Phase
- NA
Vector Delivery of the IL-12 Gene in Men With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of ATN-224 in Patients With Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer
- Status
- COMPLETED
- Phase
- NA